ONYX PHARMACEUTICALS INC Operating Leases, Rent Expense, Net
ONYX PHARMACEUTICALS INC reported Operating Leases, Rent Expense, Net of $3.20 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseNet · last filed 2013-08-09
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for the quarter ending 2013-06-30 was $3.20M, a 166.67% increase year-over-year.
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for the quarter ending 2013-03-31 was $3.60M, a 227.27% increase year-over-year.
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for the quarter ending 2012-12-31 was $2.30M, a 8.00% decline year-over-year.
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for the quarter ending 2012-09-30 was $1.30M, a 62.50% increase year-over-year.
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for fiscal 2012 was $5.80M, a 4.92% decline from fiscal 2011.
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for fiscal 2011 was $6.10M, a 41.86% increase from fiscal 2010.
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for fiscal 2010 was $4.30M, a 138.89% increase from fiscal 2009.
- ONYX PHARMACEUTICALS INC operating leases, rent expense, net for fiscal 2009 was $1.80M.
| Period end | Operating Leases, Rent Expense, Net 3 month | Operating Leases, Rent Expense, Net 6 month | Operating Leases, Rent Expense, Net 9 month | Operating Leases, Rent Expense, Net 12 month |
|---|---|---|---|---|
| 2013-06-30 | $3.20M 10-Q · filed 2013-08-09 | $7.00M 10-Q · filed 2013-08-09 | $9.10M derived: sum of 3 quarters · filed 2013-08-09 | $10.40M derived: sum of 4 quarters · filed 2013-08-09 |
| 2013-03-31 | $3.60M 10-Q · filed 2013-05-08 | $5.90M derived: sum of 2 quarters · filed 2013-05-08 | $7.20M derived: sum of 3 quarters · filed 2013-05-08 | $8.40M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.60M derived: sum of 2 quarters · filed 2013-02-28 | $4.80M derived: sum of 3 quarters · filed 2013-08-09 | $5.80M 10-K · filed 2013-02-28 |
| 2012-09-30 | $1.30M 10-Q · filed 2012-11-02 | $2.50M derived: sum of 2 quarters · filed 2013-08-09 | $3.50M 10-Q · filed 2012-11-02 | $6.10M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $1.20M 10-Q · filed 2013-08-09 | $2.20M 10-Q · filed 2013-08-09 | $4.80M derived: sum of 3 quarters · filed 2013-08-09 | $5.60M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $1.10M 10-Q · filed 2013-05-08 | $3.60M derived: sum of 2 quarters · filed 2013-05-08 | $4.40M derived: sum of 3 quarters · filed 2013-05-08 | $5.60M derived: sum of 4 quarters · filed 2013-05-08 |
| 2011-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $3.30M derived: sum of 2 quarters · filed 2013-02-28 | $4.50M derived: sum of 3 quarters · filed 2013-02-28 | $6.10M 10-K · filed 2013-02-28 |
| 2011-09-30 | $800.00K 10-Q · filed 2012-11-02 | $2.00M derived: sum of 2 quarters · filed 2012-11-02 | $3.60M 10-Q · filed 2012-11-02 | |
| 2011-06-30 | $1.20M 10-Q · filed 2012-08-06 | $2.90M 10-Q · filed 2012-08-06 | ||
| 2011-03-31 | $1.70M 10-Q · filed 2012-05-04 | |||
| 2010-12-31 | $4.30M 10-K · filed 2013-02-28 | |||
| 2009-12-31 | $1.80M 10-K · filed 2012-02-27 |